Mercedes
Iñarrairaegui Bastarrica
Consultora Médica
Medical University of Vienna
Viena, AustriaPublicaciones en colaboración con investigadores/as de Medical University of Vienna (1)
2023
-
Artificial intelligence-based pathology as a biomarker of sensitivity to atezolizumab-bevacizumab in patients with hepatocellular carcinoma: a multicentre retrospective study
The Lancet. Oncology, Vol. 24, Núm. 12, pp. 1411-1422